Scarica l'app Stockscreener
4.05
0.49%
-0.02
Dopo l'orario di chiusura:
4.07
0.02
+0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$4.07
Aprire:
$4.25
Volume 24 ore:
2.41M
Relative Volume:
0.88
Capitalizzazione di mercato:
$357.44M
Reddito:
$409.00K
Utile/perdita netta:
$-101.35M
Rapporto P/E:
-2.4695
EPS:
-1.64
Flusso di cassa netto:
$-71.49M
1 W Prestazione:
+2.53%
1M Prestazione:
+7.43%
6M Prestazione:
-22.86%
1 anno Prestazione:
-39.91%
Intervallo 1D:
$3.99
$4.25
Intervallo di 1 settimana:
$3.93
$4.25
Portata 52W:
$2.90
$11.16
Altimmune Inc Stock (ALT) Company Profile
Nome
Altimmune Inc
Settore
Industria
Telefono
(240) 654-1450
Indirizzo
910 CLOPPER ROAD, GAITHERSBURG, MD
Confronta ALT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALT
Altimmune Inc
|
4.05 | 359.21M | 409.00K | -101.35M | -71.49M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Altimmune Inc Stock (ALT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Sell |
| 2025-02-28 | Iniziato | William Blair | Mkt Perform |
| 2025-01-08 | Iniziato | Stifel | Buy |
| 2024-11-12 | Iniziato | UBS | Buy |
| 2024-04-29 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-01-24 | Iniziato | Goldman | Neutral |
| 2023-03-22 | Downgrade | Goldman | Buy → Neutral |
| 2022-12-01 | Iniziato | Goldman | Buy |
| 2021-12-29 | Ripresa | Jefferies | Buy |
| 2021-06-02 | Iniziato | H.C. Wainwright | Buy |
| 2021-02-11 | Iniziato | Guggenheim | Buy |
| 2020-12-14 | Iniziato | Jefferies | Buy |
| 2020-11-12 | Reiterato | B. Riley Securities | Buy |
| 2020-09-25 | Iniziato | B. Riley FBR | Buy |
| 2020-08-14 | Iniziato | Evercore ISI | Outperform |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-07-28 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-02-24 | Ripresa | ROTH Capital | Buy |
| 2019-07-19 | Iniziato | ROTH Capital | Buy |
| 2017-10-09 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Altimmune Inc Borsa (ALT) Ultime notizie
Altimmune (ALT) to Release Quarterly Earnings on Thursday - MarketBeat
Tools to monitor Altimmune Inc. recovery probability2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
Altimmune Inc. stock chart pattern explained2025 Dividend Review & Verified Entry Point Detection - newser.com
How strong is Altimmune Inc. stock revenue growth2025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Using AI based signals to follow Altimmune Inc.Trade Risk Assessment & Daily Chart Pattern Signals - newser.com
Automated trading signals detected on Altimmune Inc.2025 Volume Leaders & Safe Capital Growth Trade Ideas - newser.com
Moody Aldrich Partners LLC Invests $610,000 in Altimmune, Inc. $ALT - MarketBeat
Can technical indicators confirm Altimmune Inc.’s reversalMarket Risk Report & Weekly High Return Stock Opportunities - newser.com
How to use Fibonacci retracement on Altimmune Inc.Weekly Stock Report & Consistent Profit Trade Alerts - newser.com
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.
Forecasting Altimmune Inc. price range with options dataFed Meeting & Risk Managed Investment Entry Signals - newser.com
How to forecast Altimmune Inc. trends using time seriesWatch List & Free Risk Controlled Daily Trade Plans - newser.com
What technical charts say about Altimmune Inc. stockQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com
What MACD and RSI say about Altimmune Inc.2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Using fundamentals and technicals on Altimmune Inc.Risk Management & Community Consensus Stock Picks - newser.com
Should you wait for a breakout in Altimmune Inc.2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
Can momentum traders help lift Altimmune Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
Why Altimmune Inc. stock is a value investor pick2025 Risk Factors & Weekly Setup with ROI Potential - newser.com
How Altimmune Inc. stock performs during Fed tightening cyclesDip Buying & Reliable Entry Point Alerts - newser.com
Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress (NASDAQ:ALT) - Seeking Alpha
Does Altimmune Inc. show high probability of reboundJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Altimmune (Nasdaq: ALT) schedules Nov 6 results call at 8:30 a.m. ET with business update - Stock Titan
Technical analysis overview for Altimmune Inc. stockStop Loss & Capital Efficient Trade Techniques - newser.com
Published on: 2025-10-28 01:37:30 - newser.com
Altimmune Inc Azioni (ALT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):